These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 27820127)
21. An unusual cause of post-partum pyrexia. Bracewell-Milnes T; Marcus S; MacDonald R J Obstet Gynaecol; 2019 Oct; 39(7):1017-1018. PubMed ID: 31023111 [No Abstract] [Full Text] [Related]
22. Near-tetraploid acute lymphoblastic leukaemia with skeletal lesions: a unique entity? Geetha N; Ankathil R; Ramachandran V; Kumar BV; Ramachandran K; Nair AR; Rajan B Med Pediatr Oncol; 1999 Jun; 32(6):461-3. PubMed ID: 10358712 [No Abstract] [Full Text] [Related]
23. [Current treatment of philadelphia chromosome-positive acute lymphoblastic leukemia]. Sugiura I Rinsho Ketsueki; 2014 Oct; 55(10):1972-80. PubMed ID: 25297762 [No Abstract] [Full Text] [Related]
24. Successful treatment with imatinib combined with less intensive chemotherapy (vincristine and dexamethasone) as induction therapy in a very elderly patient with Philadelphia chromosome-positive acute lymphoblastic leukemia. Nishii K; Sakakura M; Tsukada T; Ryuu H; Katayama N Int J Hematol; 2007 Apr; 85(3):273-4. PubMed ID: 17483068 [No Abstract] [Full Text] [Related]
25. Ph+ALL in a pediatric patient with neuroblastoma in infancy. Suenobu S; Handa YS; Kuga S; Kakiuchi T; Akiyoshi K; Imai K; Izumi T Pediatr Int; 2010 Jun; 52(3):e147-9. PubMed ID: 20723114 [No Abstract] [Full Text] [Related]
26. [Acute lymphoblastic Ph1-positive leukemia with a hybrid phenotype. The significance of the Ph1 anomaly and the hybrid phenotype]. Nicoară S; Stefănescu D; Roman S; Tudor F; Butoianu E; Ursea C; Petrescu A; Berceanu S Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(1):85-9. PubMed ID: 2573927 [TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Ravandi F; O'Brien SM; Cortes JE; Thomas DM; Garris R; Faderl S; Burger JA; Rytting ME; Ferrajoli A; Wierda WG; Verstovsek S; Champlin R; Kebriaei P; McCue DA; Huang X; Jabbour E; Garcia-Manero G; Estrov Z; Kantarjian HM Cancer; 2015 Dec; 121(23):4158-64. PubMed ID: 26308885 [TBL] [Abstract][Full Text] [Related]
28. Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome-positive acute lymphoblastic leukemia. Sciumè M; Fracchiolla NS; Cortelezzi A Leuk Lymphoma; 2018 Oct; 59(10):2516-2517. PubMed ID: 29384412 [No Abstract] [Full Text] [Related]
29. Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation. Vigna E; Gentile M; Giagnuolo G; Recchia AG; Bossio S; De Stefano L; Morelli R; Morabito F Leuk Lymphoma; 2016 Oct; 57(10):2445-7. PubMed ID: 26879289 [No Abstract] [Full Text] [Related]
30. Long-term molecular complete remission with IFN-alpha in Ph+ adult acute lymphoid leukemia patients. Piccaluga PP; Martinelli G; Isidori A; Malagola M; Rondoni M; Paolini S; Amabile M; Iacobucci I; Baccarani M; Visani G Leukemia; 2008 Aug; 22(8):1617-8. PubMed ID: 18273047 [No Abstract] [Full Text] [Related]
31. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia. Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866 [TBL] [Abstract][Full Text] [Related]